Abstract
ObjectiveMost patients with pancreatic ductal adenocarcinoma (PDAC) will experience recurrence after resection. Here, we investigate spatially organised immune determinants of PDAC recurrence.DesignPDACs (n=284; discovery cohort) were classified according to recurrence...
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have